Unmasking the deceptive nature of cancer stem cells: The role of cd133 in revealing their secrets

J Pospieszna, H Dams-Kozlowska, W Udomsak… - International Journal of …, 2023 - mdpi.com
Cancer remains a leading cause of death globally, and its complexity poses a significant
challenge to effective treatment. Cancer stem cells and their markers have become key …

Roles of miRNAs in regulating ovarian cancer stemness

C Zhi-Xiong - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Ovarian cancer is one of the gynaecology malignancies with the highest mortality rate.
Ovarian cancer stem cell (CSC) is a subpopulation of ovarian cancer cells with increased …

Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics

MC Borlongan, H Wang - Frontiers in Cell and Developmental Biology, 2023 - frontiersin.org
Tumorigenic cancer stem cells (CSCs) represent a subpopulation of cells within the tumor
that express genetic and phenotypic profiles and signaling pathways distinct from the other …

A novel approach for transforming breast cancer stem cells into endothelial cells

QQ Mao, XC Ji, JN Zhang… - Experimental and …, 2023 - spandidos-publications.com
Tumor vascular endothelial cells play a pivotal in the tumor microenvironment, influencing
the proliferation, invasion, and metastasis of tumor progression. The present study …

[HTML][HTML] CD133, CD47, and PD-L1 Expression in Ovarian High-grade Serous Carcinoma and Its Association with Metastatic Disease: A Cross-sectional Study

R Masadah, D Ikram, R Riadi, Y Tangdiung… - Asian Pacific Journal …, 2024 - ncbi.nlm.nih.gov
Results: Strong expression of CD133 and CD47 was seen in 52% and 66% of tissue
samples, respectively. Twenty of the thirty-one patients with metastases had a significant …

[HTML][HTML] Serum CA125 and HE4 levels combined with magnetic resonance imaging (MRI) in the clinical diagnostic value of ovarian neoplasms

X Mao, W Chen - Journal of Radiation Research and Applied Sciences, 2024 - Elsevier
Objective The study aimed to assess the clinical significance of serum markers Cancer
Antigen 125 (CA125) and Human Epididymis Protein 4 (HE4) combined with MRI in …

[HTML][HTML] Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma

OD Sabunga, C Kaelan, A Zainudin… - Asian Pacific Journal …, 2022 - ncbi.nlm.nih.gov
Objective: This study evaluated the differences between IDH1-R132H and CD133
expression in different categories of astrocytoma. Material and methods: This study used a …

CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma

CM Simbulan-Rosenthal, N Islam, Y Haribabu… - Cells, 2024 - mdpi.com
CD133, a cancer stem cell (CSC) marker in tumors, including melanoma, is associated with
tumor recurrence, chemoresistance, and metastasis. Patient-derived melanoma cell lines …

MiR-145 on the proliferation of ovarian cancer cells by regulating the expression of MMP-2/MMP-9

M Wang, S Zhang - Cellular and Molecular Biology, 2021 - mail.cellmolbiol.org
This study aimed to consider the effect of miR-145 on the proliferation of OC cells by
regulating the expression of MMP-2/MMP-9. In this experiment, the miR-145 target gene with …